Concepedia
1
Publications
129
Citations
H-Index
2013
Active since
Affiliations
Exelixis (United States)(Current)
Marcus Zuzow is an author at Exelixis (United States).
Publications per year
2013–2013
<i>In Vitro</i> and <i>In Vivo</i> Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer
Frauke Bentzien, Marcus Zuzow, Nathan Heald et al. · Thyroid · 2013 · 129 citations · Full text
Rows per page
1–1 of 1